Skip to content

Stent FREDX5532-PMARecalls & reported problems

Microvention, Inc. · FRED-X 27 · Class 3 · Implant

All models of Stent (63)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
1

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00842429114490), received between Nov 14, 2022 and Dec 13, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Activation Failure” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Sep 5, 2025Open, Classified

    Flow diverter may have a manufacturing issue related to the tantalum length and/or tantalum attachment pattern, which may lead the device to be incompletely open or not properly apposed to the vessel wall, which may necessitate device recapture and withdrawal of the delivery system and microcatheter together. Insufficient apposition could lead to long-term health consequences.

    Z-0108-2026 · Root cause: Device Design · Recall details · FDA record ↗

Most reported problems

Device problems

  • Activation Failure1
  • Activation Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • Reduced Blood Flow1
  • Vascular Dissection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 13, 2024Activation Failure; Activation Failure

    IT WAS REPORTED THAT DURING TREATMENT FOR A LEFT ICA ANEURYSM, THE STENT WAS NAVIGATED THROUGH THE MICROCATHETER TO THE DISTAL LANDING ZONE. DISTAL DIAMETER MEASURED 4.07MM, PROXIMAL DIAMETER MEASURED 5.1MM, LENGTH FROM LANDING ZONE TO LANDING ZONE MEASURED 24MM. THE STENT WOULD NOT OPEN DISTALLY WHEN CROSSING THE NECK OF THE ANEURYSM, AND IT STARTED HERNIATING INTO THE ANEURYSM. THE STENT WAS RECAPTURED. WHEN DEPLOYING AGAIN, THE PHYSICIAN PERFORMED THE DEPLOYMENT DIFFERENTLY, SO THE STENT DID NOT HERNIATE AS MUCH. HOWEVER, THE STENT DID NOT OPEN FULLY ACROSS THE ANEURYSM. THE STENT WAS RECAPTURED AND WAS REDEPLOYED AGAIN. THE STENT DID OPEN PROXIMALLY, BUT IT DID NOT OPEN ACROSS THE ANEURYSM. MANIPULATION OF THE STENT WAS ATTEMPTED TO GET IT OPENED ACROSS THE NECK OF THE ANEURYSM. AFTER POST DEPLOYMENT, THERE WAS A DELAYED FILL IN THE VESSELS AS THE STENT WAS CONSTRAINED AND WAS NOT FULLY OPENED. PHYSICIAN CHOSE TO ANGIOPLASTY DEVICE WITH AN APEX BALLOON AND WAS ABLE TO CROSS THROUGH AND ANGIOPLASTY. POST ANGIOPLASTY, THE INTERMEDIATE CATHETER WAS ABLE TO CROSS THROUGH THE DEVICE. POST PROCESSING RUN WAS DONE, AND FLOW WAS BETTER, BUT STILL SLUGGISH. ANGIOPLASTY WAS DONE AGAIN, B

    Patient problems: Reduced Blood Flow; Vascular Dissection

    MAUDE report 20921744 ↗
  • InjuryNov 14, 2022Activation Problem; Activation Problem

    IT WAS REPORTED THAT THE FRED X STENT DID NOT OPPOSE COMPLETELY ON THE DISTAL PORTION OF THE WALL, AND THE MIDDLE SECTION OF THE STENT DID NOT FULLY OPEN. A BALLOON ANGIOPLASTY WAS PERFORMED ON BOTH THE DISTAL AND MIDDLE SEGMENT, AND THE MIDDLE SECTION OF THE STENT OPENED BETTER AS A RESULT. THE PATIENT WAS REPORTED TO BE DOING WELL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15795279 ↗

Other Intracranial aneurysm flow diverter devices

All Intracranial aneurysm flow diverter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page